We use cookies for analytics and ads to improve your experience. You can accept or decline. See our Privacy Policy.
Building the future of healthcare.
Managed by W Health Ventures
Private equity, private credit and real-estate funds that don't employ leverage except for operating needs. The largest AIF category.
W Health Ventures is a Mumbai and Boston-based healthcare-focused investment firm founded in 2021 by Dr. Pankaj Jethwani and backed by Sunil Wadhwani (founder of iGate). The firm operates a 'found and fund' strategy — co-founding and building generational healthcare companies from scratch alongside investing in early-stage digital health startups in India and the US. W Health Ventures Trust II (Fund II) is a SEBI Category II AIF managed by W Health Ventures GP LLP (LLPIN: ACL-1197). Fund II targets a corpus of ₹609 crore (~$70 million), building 8–10 new healthcare companies over four years in partnership with 2070 Health, India's first healthcare venture studio. W Health's investment thesis focuses on two themes proven by Fund I: single-specialty care delivery platforms that address clinical white spaces in India, and AI-enabled B2B healthcare services companies bridging India and the US. Fund II's first portfolio company is Everhope Oncology, co-founded with Narayana Health. Fund I portfolio companies including Wysa, BeatO, Mylo, BabyMD, Nivaan, and Reveal HealthTech have collectively served over 25 million patients globally.
Dr. Pankaj Jethwani
Managing Partner & CEO (2070 Health)
Dr. Pankaj Jethwani is Managing Partner of W Health Ventures and CEO of 2070 Health, India's first healthcare venture studio. He holds an MBBS from Maharashtra University of Health Sciences and an MBA from The Wharton School. His career spans clinical medicine, Boston Consulting Group (government healthcare initiatives), and founding The Breakfast Revolution (nutrition social enterprise). He serves on the boards of Wysa, Mylo, BeatO, Nivaan, Everhope Oncology, Careforce, and 2070 Health.
Gaurav Porwal
Partner & Chief Operating Officer
Gaurav Porwal is Partner and COO at W Health Ventures and COO at 2070 Health. An IIT-B and ISB alumnus, he has two decades of founder and senior leadership experience including a successful exit from Sparsh NephroCare (acquired by Fresenius Medical Care in 2016). He has previously served as COO of Global Mobility at Ola and SVP of Service Commerce at Tata Digital (Tata Neu), building healthcare, food delivery, and mobility businesses.
Bhavesh Hemani
Chief Financial Officer
Bhavesh Hemani is CFO of W Health Ventures and a Designated Partner of W Health Ventures GP LLP (the investment manager for Fund II). He is the SEBI-registered contact person for W Health Ventures Trust II.
Ashish Singh
Operating Partner
Ashish Singh is an Operating Partner at W Health Ventures, supporting portfolio companies with operational and strategic priorities.
Ajay Sondhi
Operating Partner
Ajay Sondhi is an Operating Partner at W Health Ventures, contributing expertise in healthcare operations and growth.
No insights published yet.
Investments in AIFs carry market and credit risk including possible loss of capital. Past performance does not indicate future returns. Information shown is sourced from the issuer's PPM and SEBI filings — confirm against the latest PPM before committing. wisefolio is an information platform; it is not registered with SEBI as an investment adviser, portfolio manager, or distributor. By using this page you accept our terms and privacy policy, including the self-attestation that you are eligible to view AIF marketing material under SEBI rules.
Dr. Prakash Patel
Operating Partner
Dr. Prakash Patel is an Operating Partner at W Health Ventures. He focuses on investing in therapeutics and medical device companies and has served on the boards of multiple NASDAQ-listed and private biotech/med-tech companies. He holds an MD and MBA from Tufts University School of Medicine and completed his undergraduate studies in biology and economics at Rutgers University.
View the investment manager profile with all PMS strategies and AIFs under W Health Ventures.